Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
First-line or second-line treatment of Metastatic Colorectal Cancer.
Adjuvant Stage III Colon Cancer and Metastatic Colorectal Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Targeted treatment of solid tumors and hematologic malignancies.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Treatment of patients with castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC).